Publications
Résultats 1 à 10 sur 560 Publications
| Titre | Auteurs | Année | Revue |
|---|---|---|---|
| Rationale and design of the ENGAGE study : a double-blind randomized controlled preference trial using a comprehensive cohort design to measure the effect of a cognitive and leisure-based intervention in older adults with a memory complaint. | Belleville, S.**, Moussard, A.*, Ansaldo, A.I.**, Belchior, P.**, Bherer, L.**, Bier, N., Bohbot, V.D.**, Bruneau, M.A.**, Cuddy, L.L.**, Gilbert, B., Jokel, R.**, Mahalingam, K.*, McGilton, K.**, Murphy, K.J.**, Naglie, G.**, Rochon, E.**, Troyer, A.K.**, Anderson, N.D.**. | 2019 | Trials |
| Early and late CNS inflammation in Alzheimer’s Disease: Two extremes of a continuum? | Cuello, A. C. | 2017 | Trends in Pharmacological Sciences |
| MicroPET imaging and transgenic models: a blueprint for Alzheimer’s disease clinical research | Zimmer ER, Parent MJ, Cuello AC*, Gauthier S*, Rosa-Neto P.* | 2014 | Trends in Neurosciences |
| Neuroprotection by Remote Ischemic Conditioning in Rodent Models of Focal Ischemia: a Systematic Review and Meta-Analysis | Ripley AJ, Jeffers MS, McDonald MW, Montroy J, Dykes A, Fergusson DA, Silasi G, Lalu MM, Corbett D* | 2020 | Translational Stroke Research |
| CCCDTD5: research diagnostic criteria for Alzheimer’s Disease | Gauthier S*, Chertkow H*, Theriault J, Chayer C, Ménard MC, Lacombe G, Rosa-Neto P*, Ismail Z* | 2020 | Translational Research & Clinical Interventions |
| CCCDTD5 recommendations on early non cognitive markers of dementia: A Canadian consensus | Montero-Odasso M*, Pieruccini-Faria F**, Ismail Z*, Li, K*, Lim A*, Philips N*, Kamkar N, Sarquis-Adamson Y, Speechley M*, Theou O*, Verghese J, Wallace L, Camicioli R* | 2020 | Translational Research & Clinical Interventions |
| Impact of the biological definition of Alzheimer’s disease using amyloid, tau and neurodegeneration (ATN): what about the role of vascular changes, inflammation, Lewy body pathology? | Gauthier, S.**, Zhang, H., Ng, K.P., Pascoal, T.A.*, Rosa-Neto, P.** | 2018 | Translational Neurodegeneration |
| Precision medicine in Parkinson’s disease patients with LRRK2 and GBA risk variants – Let’s get even more personal | von Listow CU, Gan-Or Z*, Brundin P | 2020 | Translational Neurodegeneration |
| Transcellular vesicular transport in epithelial and endothelial cells: Challenges and opportunities | Fung, K. Y. Y., Fairn, G. D., & Lee, W. L. | 2017 | Traffic |
| Memory Resilience to Alzheimer’s Genetic Risk: Sex Effects in Predictor Profiles | McDermott, K. L., McFall, G. P., Andrews, S. J., Anstey, K. J., & Dixon, R. A. | 2017 | The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences. |
Résultats 1 à 10 sur 560 Publications